zondag 25 december 2022

Covid Boosters are Killing Germans - and People of the World - Equally

Linear Regression Analysis of Bundeslands Booster Rate and Excess Mortality

Igor Chudov

Dec 24

, 2022

Save

▷ Listen

Dear subscriber: this article took quite a bit of work to write and it is my Christmas present to you. Please consider giving ME a Christmas present also and buy a paid subscription to my Substack. You can cancel after a month if funds are tight — I will understand and will not even know you cancelled (I am not notified of cancellations).

This article continues my “excess mortality series,” where I look at the causes of excess mortality worldwide. One of my articles compared excess mortality in many countries with vaccination rates for those countries - and found a very strong relationship.

Now we have comparable data for German “Federal Lands” called Bundeslands. It was found by a very interesting substacker, Fabian Spieker.

Vigilance per VAERS

Excess deaths and boosters by state in Germany

THIS ARTICLE IS ALSO AVAILABLE IN GERMAN Summary After having previously demonstrated that German booster waves precede German COVID-19 waves by 13 weeks which was confirmed by VAERS reports, I looked at German booster rates and German excess mortality by state…

a day ago · 5 likes · 2 comments · Fabian Spieker

His article is outstanding and sets a gold standard of what “substack anti-Covid-vax research” should be. If you like analytical research and factual “just the numbers” statistical presentations, consider subscribing to Fabian’s substack.

Here are Fabian’s notes:

Sachsen has the lowest booster rate (50.6%) and the lowest excess mortality rate (5.9%)
Thüringen has the second-lowest booster rate (54.2%) and the second-lowest excess mortality rate (8.1%)
Saarland has the second-highest booster rate (69.5%) and the second-highest excess mortality rate (12.9%)
Bremen has the third-highest booster rate (67.5%) and the third-highest excess mortality rate (11.9%)

Linear Regression

I decided to do what I am good at: I saved Fabian’s numbers and ran a linear regression to see the dependence of mortality on boosters. Here’s the data that I put in a spreadsheet:

I analyzed it with the GraphPad linear regression calculator:

It turns out that the regression finds a strong association between excess mortality and booster rates!

So, Germany provided data showing a SIGNIFICANT association of booster rates with excess mortality when broken down by region! What is interesting is that we have a same-ethnicity analysis for Germany. Unlike in country-by-country analyses, here we are not comparing Swedes with Bulgarians. We are comparing regions with ethnically the same people who speak the same language and follow the same German federal laws. And yet, much of the variation in mortality among German lands is explained by their booster rate!

Germany vs. The World - Same Relationship!

A while ago, I performed the same linear regression analysis for the entire world by country (where booster and excess mortality data is available).

Igor’s Newsletter

PROVEN RELATIONSHIP: COVID Boosters and Excess Mortality in 2022

This article will show that there is a very strong statistically significant association between excess mortality in 2022, and uptake of COVID boosters. The booster rate as of Jul 1 explains excess deaths in 2022, by country, using linear regression with R^2 = 40% and P-value an incredible 0.0002…

4 months ago · 515 likes · 493 comments · Igor Chudov

I used somewhat different time periods. And yet, the linear fit for the whole world is remarkably similar to that for the Bundeslands in Germany! Reproducing the fits from my world analysis:

(Chile really had 125 boosters per 100 persons, and yes, it has the highest excess mortality)

Looks quite similar? Here are the equations of the straight lines:

World:   Excess Mortality = 0.1675 * Booster Rate + 0.02387
Germany: Excess Mortality = 0.1732 * Booster Rate - 0.047

The equations are extremely similar, even though they are based on completely different data sets and somewhat different time periods!

Why are the lines for Germany and the entire world so similar? The reason is that Covid vaccines affect people similarly, wherever they are given. The similarity of the linear dependence between boosters and mortality, obtained from completely different data sets, proves that the relationship is real!

Is this not proof that Covid vaccines and boosters cause death?

I am sure that the good citizens of Germany, and citizens of the entire world, did not expect that boosters would cause excess mortality. We all were told that the vaccines were “safe and effective.” Everyone agreed! The newspapers told us. The politicians told us. And yet, now boosters cause excess mortality.

I am very sorry about this outcome. It was not my idea to administer these shots. Perfectly good people believed in science, their press, and their politicians. Unfortunately, that belief was misplaced: charlatans hijacked the science, and crooks bought the press.

Will the excess mortality end soon? What do you think?

POLL

What will happen to excess mortality?

Let us know what you think! Tell us why you selected your answer to the poll!

You're currently a free subscriber to Igor’s Newsletter. For the full experience, upgrade your subscription.

Upgrade to paid

Comment

Study Confirms that Molnupiravir Creates "Variant Soup". How could the FDA Approve It?

Molnupiravir can cause DNA mutations and cancer in people

Igor Chudov

Dec 23

, 2022

Save

▷ Listen

A couple of weeks ago, I made a post that alleged that Molnupiravir, a mutagenic drug that makes the RNA of Sars-Cov-2 mutate, causes new COVID variants to appear faster than before.

Igor’s Newsletter

Did Molnupiravir Create the Recent "COVID Variant Soup"?

There are two Covid-specific drugs. One is Paxlovid, developed by Pfizer, which causes “Paxlovid rebounds” and was not tested by Pfizer on vaccinated people. I wrote about a dozen articles on it, exposing it as snake oil, and this one is a good summary…

13 days ago · 341 likes · 173 comments · Igor Chudov

A preprint for a new scientific study was just published that confirms this contention.

Before we consider this study, let me point out that most mutations (in viruses and animals) are deadly and make the organism unable to reproduce. Such was the hope with Molnupiravir: its designers expected that mutations caused by the drug would make the Sars-Cov-2 virus unable to reproduce, thus stopping the infection.

The problem is that SOME mutated copies remain viable - and create new variants!

The study took nine immunocompromised patients, gave Molnupiravir to five, and used four as controls. Within days, the five treated patients developed numerous mutations in the viruses that infected them:

Here, we used a case-control approach to monitor SARS-CoV-2 18 genomes through time in nine immunocompromised -patients with five treated with 19 Molnupiravir. Within days of treatment, we detected a large number of low-frequency mutations in patients and that these new mutations could persist and, in some cases, were fixed in the virus population. All patients treated with the drug accrued new mutations in the spike protein of the virus, including non-synonymous mutations that altered the amino acid sequence. Our study demonstrates that this commonly used antiviral can ‘supercharge’ viral evolution in immunocompromised patients, potentially generating new variants and 25 prolonging the pandemic.

Note that the study used immunocompromised patients who cannot clear the virus easily. However, it is entirely possible that even immunocompetent people on Molnupiravir would acquire similar mutations. As we know that the boosted people are the slowest to clear Covid-19, they would be at special risk of developing and passing on new mutated copies of Sars-Cov-2.

Here’s the figure showing the Molnupiravir-treated patients created mutated strains of Sars-Cov-2, compared to the controls:

This confirms that Molnupiravir creates variants. Most mutations that happen are NOT helpful to the virus and reduce its “fitness.” Some, however, create new variants and contribute to the crazy “variant soup” we are seeing.

We Were Warned

In 2021, William Haseltine, a prominent virologist formerly at Harvard University, warned us about Molnupiravir unleashing new variants.

Now, William Haseltine, a virologist formerly at Harvard University known for his work on HIV and the human genome project, suggests that by inducing viral mutations, molnupiravir could spur the rise of new viral variants more dangerous than today’s. “You are putting a drug into circulation that is a potent mutagen at a time when we are deeply concerned about new variants,” says Haseltine, who outlined his concern Monday in a Forbes blog post. “I can’t imagine doing anything more dangerous.”

Molnupiravir Likely Promotes DNA Mutations in People, Causing Birth Defects and Cancer

Concerns about the mutagenicity of Molnupiravir in humans are not new. Here’s a letter to the BMJ warning about it:

Last summer, when an associate of mine had Covid, a doctor proposed that I give them Molnupiravir. I am so glad that I declined and gave them Ivermectin instead. (Covid went away in 1-2 days)

All these concerns were outlined a year ago. They are now being confirmed.

Even worse, they were raised at the FDA advisers meeting.

The expert panel voted 13-10 that the pill, called molnupiravir, should be authorized, although members expressed concerns that, if used in pregnancy it could cause birth defects. During the panel, discussions frequently turned to whether or not panelists trusted the effectiveness data on the drug, even when they were discussing other topics.
Panelists also worried about data showing that use of molnupiravir might, in theory, lead to new variants of the SARS-CoV-2 virus through its mechanism, which works by causing viruses to make mistakes in copying their genetic material.

One of the FDA’s so-called “experts” explains his YES vote:

“This was clearly a difficult decision,” said Michael Green, an infectious disease expert at the University of Pittsburgh, in explaining his “yes” vote.

I am sorry, Dr. Green, but it was not a difficult decision — you should have voted NO.

How could the FDA approve Molnupiravir, given that they knew all about the potential for deadly consequences?